The latest market intelligence study by Infiniti Research on fractional flow reserve (FFR) technology provides insights on the introduction of new drugs and innovative technologies in the healthcare sector.
FFR technology to revolutionize the healthcare industry
The introduction of FFR technology is helping in the management of coronary artery disease (CAD). This new age invasive tool is extremely useful and is improving patient outcomes and reducing healthcare costs around the globe. The launch of new drugs in the market will boost the usage of FFR technology in the market. This method is designed to help physicians determine the need for stenting for each patient. Furthermore, FFR examinations help avoid unnecessary cardiac stent placements and further reduce the risk of myocardial ischemia and infarction. The FFR manufacturers are using market intelligence solutions to analyze business risks and identify investment opportunities that will boost their profitability in the global market.
The influx of new entrants in the FFR market will not only raise the competition bar but also increase the number of products that are available in the market. Seeing this competitiveness, many healthcare giants are gaining the US FDA approvals to launch new FFR products and maintain their position in the market.